Ironwood Pharmaceuticals Stock Price Patterns
| IRWD Stock | USD 4.94 0.05 1.02% |
Momentum 67
Buy Stretched
Oversold | Overbought |
Quarterly Earnings Growth 10.468 | EPS Estimate Next Quarter 0.125 | EPS Estimate Current Year 0.255 | EPS Estimate Next Year 0.8533 | Wall Street Target Price 4.85 |
Using Ironwood Pharmaceuticals hype-based prediction, you can estimate the value of Ironwood Pharmaceuticals from the perspective of Ironwood Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Ironwood Pharmaceuticals using Ironwood Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Ironwood using crowd psychology based on the activity and movement of Ironwood Pharmaceuticals' stock price.
Ironwood Pharmaceuticals Short Interest
A significant increase or decrease in Ironwood Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Ironwood. Short interest can provide insight into the potential direction of Ironwood Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.8143 | Short Percent 0.0839 | Short Ratio 1.26 | Shares Short Prior Month 8.1 M | 50 Day MA 3.9084 |
Ironwood Pharmaceuticals Hype to Price Pattern
Investor biases related to Ironwood Pharmaceuticals' public news can be used to forecast risks associated with an investment in Ironwood. The trend in average sentiment can be used to explain how an investor holding Ironwood can time the market purely based on public headlines and social activities around Ironwood Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ironwood Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals Implied Volatility | 1.56 |
Ironwood Pharmaceuticals' implied volatility exposes the market's sentiment of Ironwood Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ironwood Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Ironwood Pharmaceuticals stock will not fluctuate a lot when Ironwood Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Ironwood Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Ironwood because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ironwood Pharmaceuticals after-hype prediction price | USD 4.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Ironwood contract
Based on the Rule 16, the options market is currently suggesting that Ironwood Pharmaceuticals will have an average daily up or down price movement of about 0.0975% per day over the life of the 2026-05-15 option contract. With Ironwood Pharmaceuticals trading at USD 4.94, that is roughly USD 0.004817 . If you think that the market is fully incorporating Ironwood Pharmaceuticals' daily price movement you should consider acquiring Ironwood Pharmaceuticals options at the current volatility level of 1.56%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Ironwood Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ironwood Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ironwood Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Ironwood Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ironwood Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ironwood Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ironwood Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Ironwood Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ironwood Pharmaceuticals' historical news coverage. Ironwood Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.25 and 12.50, respectively. We have considered Ironwood Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ironwood Pharmaceuticals is very risky at this time. Analysis and calculation of next after-hype price of Ironwood Pharmaceuticals is based on 3 months time horizon.
Ironwood Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Ironwood Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ironwood Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ironwood Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.73 | 7.62 | 0.57 | 0.34 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.94 | 4.94 | 0.00 |
|
Ironwood Pharmaceuticals Hype Timeline
Ironwood Pharmaceuticals is currently traded for 4.94. The entity has historical hype elasticity of -0.57, and average elasticity to hype of competition of -0.34. Ironwood is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 1.73%. %. The volatility of related hype on Ironwood Pharmaceuticals is about 3927.84%, with the expected price after the next announcement by competition of 4.60. About 92.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 2nd of April 1970. Ironwood Pharmaceuticals had 1194:1000 split on the 2nd of April 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Ironwood Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Ironwood Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Ironwood Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Ironwood Pharmaceuticals' future price movements. Getting to know how Ironwood Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ironwood Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CGC | Canopy Growth Corp | (0.03) | 13 per month | 4.76 | 0.02 | 8.55 | (9.16) | 66.41 | |
| TKNO | Alpha Teknova | (0.27) | 6 per month | 0.00 | (0.28) | 4.75 | (8.07) | 23.61 | |
| LFCR | Lifecore Biomedical | (0.23) | 9 per month | 2.38 | 0.06 | 6.17 | (4.51) | 15.24 | |
| ACB | Aurora Cannabis | (0.04) | 7 per month | 0.00 | (0.1) | 3.56 | (5.19) | 26.49 | |
| BIOA | BioAge Labs | (1.41) | 8 per month | 2.63 | 0.25 | 13.88 | (6.06) | 33.50 | |
| GNLX | Genelux Common | (0.20) | 8 per month | 0.00 | (0.21) | 5.67 | (11.87) | 35.77 | |
| NPCE | Neuropace | (0.01) | 10 per month | 2.00 | 0.14 | 6.30 | (4.34) | 43.20 | |
| ALDX | Aldeyra | 0.23 | 8 per month | 4.28 | 0.04 | 6.27 | (8.84) | 42.93 | |
| SLN | Silence Therapeutics PLC | 0.14 | 7 per month | 0.00 | (0.15) | 6.88 | (5.89) | 22.91 | |
| CLLS | Cellectis SA | (0.12) | 8 per month | 4.40 | 0.03 | 9.24 | (7.69) | 29.31 |
Ironwood Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Ironwood price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ironwood using various technical indicators. When you analyze Ironwood charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ironwood Pharmaceuticals Predictive Indicators
The successful prediction of Ironwood Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ironwood Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ironwood Pharmaceuticals based on analysis of Ironwood Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ironwood Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ironwood Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Payables Turnover | 3.2 | 3.04 | Days Of Inventory On Hand | 370.02 | 671.81 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Ironwood Stock analysis
When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |